Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 9629 

for health care services rendered to 

Medicare beneficiaries. CMS requires 

that providers follow reasonable cost 

principles under 1861(v)(1)(A) of the 

Act when completing the Medicare cost 

report (MCR). Regulations at 42 CFR 

413.20 and 413.24 require that providers 

submit acceptable cost reports on an 

annual basis and maintain sufficient 

financial records and statistical data, 

capable of verification by qualified 

auditors. 

ESRD facilities participating in the 

Medicare program submit these cost 

reports annually to report cost and 

statistical data used by CMS to 

determine reasonable costs incurred for 

furnishing dialysis services to Medicare 

beneficiaries and to effect the year-end 

cost settlement for Medicare bad debts. 

Form Number: CMS–265–11 (OMB 

control number: 0938–0236); Frequency: 

Annually; Affected Public: Private 

Sector, Business or other for-profits, 

State, Local, or Tribal Governments); 

Number of Respondents: 7,492; Total 

Annual Responses: 7,492; Total Annual 

Hours: 494,472. (For questions regarding 

this collection contact Keplinger, Jill C 

at 410–786–4550.) 

5. Type of Information Collection 

Request: Reinstatement without change; 

Title of Information Collection: Good 

Cause Processes; Use: Section 

1851(g)(3)(B)(i) of the Act provides that 

MA organizations may terminate the 

enrollment of individuals who fail to 

pay basic and supplemental premiums 

after a grace period established by the 

plan. Section 1860D–1(b)(1)(B)(v) of the 

Act generally directs us to establish 

rules related to enrollment, 

disenrollment, and termination for Part 

D plan sponsors that are similar to those 

established for MA organizations under 

section 1851 of the Act. Consistent with 

these sections of the Act, subpart B in 

each of the Parts C and D regulations 

sets forth requirements with respect to 

involuntary disenrollment procedures at 

42 CFR 422.74 and 423.44, respectively. 

In addition, section 1876(c)(3)(B) 

establishes that individuals may be 

disenrolled from coverage as specified 

in regulations. Thus, current regulations 

at 42 CFR 417.460 specify that a cost 

plan, specifically a Health Maintenance 

Organization (HMO) or competitive 

medical plan (CMP), may disenroll a 

member who fails to pay premiums or 

other charges imposed by the plan for 

deductible and coinsurance amounts. 

These good cause provisions 

authorize CMS to reinstate a disenrolled 

individual’s enrollment without 

interruption in coverage if the nonpayment is due to circumstances that 

the individual could not reasonably 

foresee or could not control, such as an 

unexpected hospitalization. At its 

inception, the process of accepting, 

reviewing, and processing beneficiary 

requests for reinstatement for good 

cause was carried out exclusively by 

CMS. Form Number: CMS–10544 (OMB 

control number: 0938–1271); Frequency: 

Annually; Affected Public: Business or 

other for-profits State, Local, or Tribal 

Governments); Number of Respondents: 

312; Total Annual Responses: 41,289; 

Total Annual Hours: 27,499. (For 

questions regarding this collection 

contact Fabayo, Ronke at (410) 786– 

4460.) 

Dated: February 16, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–03727 Filed 2–18–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

OMB No. 0970–0502 

Proposed Information Collection 

Activity; Behavioral Interventions To 

Advance Self-Sufficiency Next 

Generation 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Office of Planning, 

Research, and Evaluation (OPRE) in the 

Administration for Children and 

Families (ACF), U.S. Department of 

Health and Human Services (HHS), 

requests Office of Management and 

Budget (OMB) approval to extend 

approval of the ACF Behavioral 

Interventions to Advance SelfSufficiency Next Generation (BIAS–NG) 

Project Overarching Generic (OMB #: 

0970–0502; Expiration date: 8/31/2022). 

Under this overarching generic, ACF 

collects data as part of rapid cycle 

testing and evaluation, in order to 

inform the design of interventions 

informed by behavioral science and to 

better understand the mechanisms and 

effects of such interventions. 

Interventions have been and will 

continue to be developed in the program 

area domains of Temporary Assistance 

for Needy Families (TANF), child 

welfare, and Early Head Start/Head Start 

(EHS/HS). These interventions are 

intended to improve outcomes for 

participants in these programs. No 

changes are proposed. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: OPRE is conducting the 

BIAS–NG project, which uses 

behavioral insights to design and test 

interventions intended to improve the 

efficiency, operations, and efficacy of 

human services programs. The BIAS– 

NG project is applying and testing 

behavioral insights to ACF programs 

including TANF, Child Welfare, and 

EHS/HS. This notice is a request for 

comments on ACF’s proposal to extend 

approval of the overarching generic. 

Under the approved pilot generic 

clearance, OPRE has already completed 

work with five sites and has conducted 

five tests. The extended approval would 

allow OPRE to continue to work with at 

least three additional sites, conducting 

one or more tests of behavioral 

interventions. The design and testing of 

BIAS–NG interventions is rapid and, to 

the extent possible, iterative. Each 

specific intervention is designed in 

consultation with agency leaders and 

launched as quickly as possible. To 

maximize the likelihood that the 

intervention produces measurable, 

significant, and positive effects on 

outcomes of interest, rapid cycle 

evaluation techniques will be employed 

in which proximate outcomes will be 

measured to allow the research team to 

more quickly iterate and adjust the 

intervention design, informing 

subsequent tests. Due to the rapid and 

iterative nature of this work, OPRE 

sought and received generic clearance to 

conduct this research. Following 

standard OMB requirements for generic 

clearances, once instruments requiring 

burden are tailored to a specific site and 

the site’s intervention, OPRE submits an 

individual generic information 

collection request under this umbrella 

clearance. Each request includes the 

individual instrument(s), a justification 

specific to the individual information 

collection, a description of the proposed 

intervention, and any supplementary 

documents. Each specific information 

collection includes up to two 

submissions—one submission for the 

formative stage research and another 

submission for any further data 


lotter on DSK11XQN23PROD with NOTICES1
9630 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 

collection requiring burden during the 

testing phase. The type of information to 

be collected and the uses of the 

information is described in the 

supporting statements, found here: 

https://www.reginfo.gov/public/do/ 

PRAViewDocument?ref_nbr=201707- 

0970-005. 

Respondents: (1) Program 

Administrators, (2) Program Staff, and 

(3) Program Clients. 

ANNUAL BURDEN ESTIMATES

[TANF, CW, EHS/HS] 

Instrument 

Number of 

respondents 

(TANF, CW, 

EHS/HS) (total 

over request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden hours 

per response 

(in hours) 

Total burden 

(in hours) 

Annual burden 

(in hours) 

Phase 3: Diagnosis and Design 

Administrator interviews/focus groups ................................. 48 1 1 48 16 

Staff interviews/focus groups ............................................... 400 1 1 400 133 

Client interviews/focus groups ............................................. 400 1 1 400 133 

Client survey ........................................................................ 400 1 0.25 100 33 

Staff Survey ......................................................................... 400 1 0.25 100 33 

Phase 4: Evaluation 

Administrator interviews/focus groups ................................. 96 1 1 96 32 

Staff interviews/focus groups ............................................... 800 1 1 800 267 

Client interviews/focus groups ............................................. 800 1 1 800 267 

Client survey ........................................................................ 12,000 1 0.25 3,000 1,000 

Staff Survey ......................................................................... 1,200 1 0.25 300 100 

Estimated Total Annual Burden 

Hours: 2,014. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 42 U.S.C. 1310. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–03669 Filed 2–18–22; 8:45 am] 

BILLING CODE 4184–07–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Detecting Cognitive 

Impairment, Including Dementia, in Primary 

Care and Other Everyday Clinical Settings for 

the General Public and Health Equity, 

Pragmatic Clinical Trials (U01 Clinical Trial 

Required). 

Date: March 29, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Ana Olariu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Boulevard, 

Room 3208, MSC 9529, Bethesda, MD 20892, 

301–496–9223 Ana.Olariu@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; BRAIN Initiative Advanced 

Postdoctoral Career Transition Award to 

Promote Diversity (K99/R00 Independent 

Clinical Trial Not Allowed). 

Date: March 30, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Lataisia Cherie Jones, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, NINDS/NIH, NSC, 6001 Executive 

Boulevard, Suite 3208, Rockville, MD 20852, 

301–496–9223, lataisia.jones@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Diversity K01 & MOSAIC 

Postdoctoral Career Transition Award to 

Promote Diversity (K99/R00 Independent 

Clinical Trial Not Allowed). 

Date: March 31, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Lataisia Cherie Jones, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, NINDS/NIH, NSC, 6001 Executive 

Boulevard, Suite 3208, Rockville, MD 20852, 

301–496–9223, lataisia.jones@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 


lotter on DSK11XQN23PROD with NOTICES1